272
U. Boas et al. / Tetrahedron Letters 45 (2004) 269–272
16. Barlos, K.; Gatos, D.; Kallitis, J.; Papaphotiu, G.; Sotiriu,
P.; Yao, W. Q.; Schafer, W. Tetrahedron Lett. 1989, 3943–
3946.
(101 MHz, d6-DMSO): d 28.3, 39.0, 40.2, 77.8, 127.1,
129.3, 129.5, 155.7, 167.2; HPLC (220 nm): tR
¼
18:061 min; 99% crude purity; HR-MS (TOF-ESþ) calcd
for C16H24N3O4S (MHþ) 354.1487 (mono-isotopic);
found. 354.1492 (7): 1H NMR (400 MHz, d6-DMSO): d
2.45 (t, poorly resolved, 2H), 3.49(br t, 2H), 4.75 (br s,
2H), 7.38 (d, J ¼ 8:4 Hz, 2H), 7.59(br s, 1H), 7.88 (d,
J ¼ 6:6 Hz, 2H), 8.05 (br s, 1H). 13C (101 MHz, d6-
DMSO): d 38.9, 40.2, 59.6, 127.2, 129.3, 132.9, 142.1,
167.3, 170.1; HPLC (220 nm): tR ¼ 15:201 min; 99% crude
purity; HR-MS (TOF-ESþ) calcd for C11H15N2O3S
(MHþ) 255.0803 (mono-isotopic); found. 255.0825 (8):
1H NMR (400 MHz, d6-DMSO): d 1.50–1.70 (m, 10H),
1.75 (m, 3H), 4.68 (br d, J ¼ 5:3 Hz, 2H), 7.17 (br s, 1H),
7.30 (d, J ¼ 8:2 Hz, 2H), 7.75 (br t, J ¼ 5:4 Hz, 1H), 7.82
(d, J ¼ 8:2 Hz, 2H); 13C (101 MHz, d6-DMSO): d 28.4,
29.0, 35.2, 36.0, 38.6, 40.6, 41.2, 42.0, 46.2, 49.2, 50.8, 52.9,
126.9, 127.0, 129.3, 143.7, 167.8, 181.5; HPLC (220 nm):
tR ¼ 19:457 min; 93% crude purity; HR-MS (TOF-ESþ)
calcd for C19H25N2O2S (MHþ) 345.1637 (mono-isotopic);
found. 345.1680 (9): 1H NMR (400 MHz, d6-DMSO): d
3.15 (d, J ¼ 5:3 Hz, 2H), 3.50 (s, 3H), 5.12 (q, J ¼ 5:9Hz,
1H), 7.11–7.35 (m, 6H), 8.03 (d, J ¼ 8:6 Hz, 1H), 12.72 (br
s, 1H); 13C (101 MHz, d6-DMSO): d 53.7, 57.1, 63.1, 128.2,
17. SPS of thioureas, general procedure: Deprotected amino
acid derivatised 2-chlorotrityl resin (0.10 g, 0.19mmol,
theoretical loading: 1.9mmol/g) was suspended in DMF
(0.50 mL). Carbon disulfide (1.00 mL) was added followed
by HBTU (0.29g, 0.76 mmol) or PyBOP (0.40 g,
0.76 mmol) and DIPEA (0.39mL, 2.28 mmol). The sus-
pension was shaken for 30 min at rt. The solvent was
removed by suction, and the resin was washed with DCM
(10 times), DMF (5 times), and air was flushed through for
10 min to remove residual carbon disulfide. The deriva-
tised resin was swelled in DMF (1.5 mL) and amine
(5 equiv, 0.95 mmol) was added. If the amine was a
hydrochloride, DIPEA (0.33 mL, 1.9mmol) was added
and the mixture was shaken for 2 h at rt. The solvent was
removed by suction and the resin was washed with DMF
(5 times) and DCM (5 times). The thiourea compound was
released from the resin using 20% HFIP (2.5 mL) for
30 min, the product was collected by suction and the
cleavage mixture was removed in vacuo.
18. Analytical data for compounds 1–9: (1): 1H NMR
(250 MHz, d6-DMSO): d 1.27 (s, 9H), 2.93 (m, 2H), 4.64
(d, J ¼ 4:9Hz, 2H), 5.15 (br q, 1H), 6.85 (d, J ¼ 8:4 Hz,
2H), 7.10 (d, J ¼ 8:4 Hz, 2H), 7.23 (m, 5H), 7.58 (d,
J ¼ 7:7 Hz, 1H), 8.12 (t, J ¼ 5:5 Hz, 1H); 13C (63 MHz,
d6-DMSO): d 28.6, 36.6, 47.1, 57.8, 77.8, 123.4, 123.6,
126.9, 127.0, 127.3, 128.2, 128.3, 129.8, 130.3, 131.7, 139.1,
153.7, 173.2, 182.9. HPLC (220 nm): tR ¼ 22:549min; 97%
crude purity. HR-MS (TOF-ESþ) calcd for C21H27N2O3S
(MHþ) 387.1739(mono-isotopic); found. 387.1739( 2): 1H
NMR (250 MHz, d6-DMSO): d 4.62 (br s, 2H), 4.75 (br s,
2H), 7.25–7.40 (m, 7H), 7.90 (d, J ¼ 7:3 Hz, 2H), 8.05 (br
s, 2H), 12.71 (br s, 1H). 13C (63 MHz, d6-DMSO): d 46.6,
47.0, 126.9, 127.1, 127.3, 128.3, 129.4, 144.7, 167.3; HPLC
(220 nm): tR ¼ 18:468 min; 98% crude purity; HR-MS
(TOF-ESþ) calcd for C16H17N2O2S (MHþ) 301.1037
(mono-isotopic); found. 301.1073 (3): 1H NMR (250 MHz,
d6-DMSO): d 1.27 (qn, J ¼ 6:6 Hz, 2H), 1.50 (m, 4H), 2.20
(t, J ¼ 7:3 Hz, 2H), 4.64 (br s, 2H), 7.15–7.40 (m, 5H), 7.50
(br s, 1H), 7.80 (br s, 1H); 13C (63 MHz, d6-DMSO): d
24.3, 26.0, 28.6, 33.8, 43.5, 46.9, 126.8, 127.3, 128.3, 139.9,
174.6; HPLC (220 nm): tR ¼ 18:633 min; 98% crude purity;
HR-MS (TOF-ESþ) calcd for C14H21N2O2S (MHþ)
129.2,
137.6,
172.7,
179.5;
HPLC
(220 nm):
tR ¼ 16:572 min; 95% crude purity; HR-MS (TOF-ESþ)
calcd for C11H15N2O3S (MHþ) 255.0803 (mono-isotopic);
found. 255.0797.
19. The yields are based on the amount of amino acid coupled
to the resin. The actual loading of amino acid was
determined by Fmoc quantification: 5 mg resin (ca.
10 lmol theoretical loading) was swelled in 20% piper-
idine/DMF (25 mL), the mixture was shaken for 30 min
and the absorption (290 nm) was measured. A 20%
piperidine/DMF solution was used as reference.
20. IR-spectral data can be found in the supporting information.
21. Dolphin, D.; Wick, A. Tabulation of Infrared Spectral
Data; Wiley & Sons, 1977; p 412.
22. 4-Isothiocyanatomethylbenzoic acid: Deprotected amino
acid derivatised 2-chlorotrityl resin (0.10 g, 0.19mmol)
was suspended in DMF (0.50 mL). Carbon disulfide
(1.00 mL) was added followed by HBTU (0.29g,
0.76 mmol) or PyBOP (0.40 g, 0.76 mmol) and DIPEA
(0.39mL, 2.28 mmol). The suspension was shaken for
30 min at rt. The solvent was removed by suction, and the
resin was washed with DCM (10 times), DMF (5 times),
and air was flushed through for 10 min to remove residual
carbon disulfide. The isothiocyanate was released from the
resin by 20% HFIP (2.5 mL) for 30 min, the product was
collected by suction and the cleavage mixture was removed
in vacuo, the product was obtained as an off-white
powder. Yield (HBTU): 13.6 mg (76%); Yield (PyBOP):
13.8 mg (77%). 1H NMR (400 MHz, CDCl3): d 4.77 (s,
1
281.1324 (mono-isotopic); found. 281.1319( 4): H NMR
(400 MHz, d6-DMSO): d 1.30 (d, J2 ¼ 7:1 Hz, 3H), 1.40 (s,
9H), 2.95 (dd, J1 ¼ 13:7 Hz, J2 ¼ 6:4 Hz, 2H), 4.60 (qn,
J ¼ 7:1 Hz, 1H), 4.95 (br q, 1H), 7.20–7.30 (m, 5H), 7.65
(br d, J ¼ 7:1 Hz, 1H), 8.00 (br d, J ¼ 6:2 Hz, 1H), 10.20
(br s, 1H); 13C (101 MHz, d6-DMSO): d 27.7, 31.4, 37.2,
52.7, 57.7, 80.5, 126.4, 128.1, 129.4, 137.2, 171.9, 172.8,
182.1; HPLC (220 nm): tR ¼ 22:632 min; 99% crude purity
HR-MS (TOF-ESþ) calcd for C17H25N2O4S (MHþ)
2H), 7.38 (d, J ¼ 8:1 Hz, 2H), 8.07 (d, J ¼ 8:2 Hz, 2H); 13
C
1
353.1535 (mono-isotopic); found. 353.1547 (5): H NMR
(400 MHz, d6-DMSO):
(101 MHz, CDCl3): d 47.4, 125.7, 128.4, 129.8, 130.0 (low
intensity); 139.0, 152.4; HPLC (220 nm): tR ¼ 21.066 min;
97% crude purity; MS (FABþ) calcd for C9H7NO2S (m=z)
193.23; found. 216.96 (M+Naþ).
d 2.80–3.05 (m, 4H), 4.11
(d, J ¼ 10:1 Hz, 2H), 4.40 (m, 2H), 4.92 (br s, 2H), 7.15–
7.30 (m, 10H), 7.80 (br s, 1H), 7.92 (br s, 1H), 8.17 (br d,
1H), 10.42 (br s, 1H); 13C (101 MHz, d6-DMSO): d 42.3,
47.0, 58.3, 59.8, 67.3, 126.3, 126.9, 127.8, 128.3, 129.2,
129.3, 129.5, 130.2, 135.2, 137.5, 137.8, 138.1, 165.3, 168.4,
172.6, 182.3; HPLC (220 nm): tR ¼ 20:824 min; 90% crude
purity; HR-MS (TOF-ESþ) calcd for C21H25N4O4S
(MHþ) 429.1596 (mono-isotopic); found. 429.1606 (6):
1H NMR (400 MHz, d6-DMSO): d 1.38 (s, 9H), 3.08 (q,
J ¼ 5:9Hz, 2H), 3.48 (br s, 2H), 4.73 (br s, 2H), 6.85 (br s,
1H), 7.38 (d, J ¼ 8:4 Hz, 2H), 7.60 (br t, 1H), 7.88 (d,
J ¼ 8:4 Hz, 2H), 8.05 (br s, 1H), 12.60 (br s, 1H); 13C
23. Nowick, J.; Holmes, D. L.; Noronba, G.; Smith, E. M.;
Nguyen, T. M.; Huang, S.-L. J. Org. Chem. 1996, 61,
3929–3934.
24. A way to circumvent the formation of thiohydantoins
could be to introduce 2-hydroxy-4-methoxybenzyl (Hmb)
protection of the last backbone amide at the N-terminal.
The Hmb group has found wide use for preventing peptide
aggregation during Fmoc solid-phase peptide synthesis,
see for example, Johnson, T.; Quibell, M. Tetrahedron
Lett. 1994, 35, 463–466.